We heard you. Our native WikEM app is back! Download from your app store now (iOS and Android).

View source for Tirzepatide

← Tirzepatide

You do not have permission to edit this page, for the following reasons:

The action you have requested is limited to users in the group: writer.
You must confirm your email address before editing pages. Please set and validate your email address through your user preferences.

You can view and copy the source of this page.

Tirzepatide is a dual GIP and GLP-1 agonist approved for the treatment of type 2 diabetes and also used off-label for obesity treatment

==Side Effects==
*Pancreatitis
*Nausea
*Vomiting
*Abdominal pain

==References==
<references/>

[[Category:Pharmacology]]

Return to Tirzepatide.

Retrieved from "https://www.wikem.org/wiki/Tirzepatide"